Tris(4-(9H-carbazol-9-yl)phenyl)amine

Catalog No. :
ACPYKL836
CAS No. :
139092-78-7
Molecular Formula :
C54H36N4
Molecular Weight :
740.91

IUPAC Name:tris(4-(9H-carbazol-9-yl)phenyl)amine

Tris(4-(9H-carbazol-9-yl)phenyl)amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$111.00Login to see priceIn stockInquiry
25g98%$332.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameTris(4-(9H-carbazol-9-yl)phenyl)amine
IUPAC Nametris(4-(9H-carbazol-9-yl)phenyl)amine
MDL No.MFCD03093250
Molecular FormulaC54H36N4
Molecular Weight740.91
SMILESN(C1=CC=C(N2C3=C(C4=C2C=CC=C4)C=CC=C3)C=C1)(C5=CC=C(N6C7=C(C8=C6C=CC=C8)C=CC=C7)C=C5)C9=CC=C(N%10C%11=C(C%12=C%10C=CC=C%12)C=CC=C%11)C=C9
InChI KeyAWXGSYPUMWKTBR-UHFFFAOYSA-N
SynonymTCTA | 4-(9H-CARBAZOL-9-YL)-N,N-BIS[4-(9H-CARBAZOL-9-YL)PHENYL]ANILINE | tris(4-(9H-carbazol-9-yl)phenyl)amine | 4,4',4''-Tri-9-carbazolyltriphenylamine | Tris(4-carbazoyl-9-ylphenyl)amine | CS-W011400 | SY052830 | Tris[4-(9H-carbazol-9-yl)phenyl]amine |
CAS No.139092-78-7
PubChem CID9962045

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACPYKL836 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPYKL836 route product structure diagram
    ACPYKL836139092-78-7 In Stock
Inquiry

2. ACPYKL836 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJVZS630 route compound structure diagram
    ACJVZS63057103-15-8 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPYKL836 route product structure diagram
    ACPYKL836139092-78-7 In Stock
Inquiry

Comments (0)